Articles with public access mandates - Dawn F. Ionescu, M.D.Learn more
Not available anywhere: 9
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
GI Papakostas, DF Ionescu
Molecular psychiatry 20 (10), 1142-1150, 2015
Mandates: US National Institutes of Health
Classics in chemical neuroscience: ketamine
MW Tyler, HB Yourish, DF Ionescu, SJ Haggarty
ACS chemical neuroscience 8 (6), 1122-1134, 2017
Mandates: US National Institutes of Health
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine
DF Ionescu, DA Luckenbaugh, MJ Niciu, EM Richards, EE Slonena, ...
The Journal of clinical psychiatry 75 (9), 5470, 2014
Mandates: US National Institutes of Health
Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine
MC Zeng, MJ Niciu, DA Luckenbaugh, DF Ionescu, DC Mathews, ...
Biological psychiatry 73 (12), e37-e38, 2013
Mandates: US National Institutes of Health
Effect of concomitant benzodiazepines on the antidepressant effects of ketamine: findings from the RAPID intravenous ketamine study
A Feeney, BB Hoeppner, MP Freeman, M Flynn, DV Iosifescu, MH Trivedi, ...
The Journal of Clinical Psychiatry 84 (1), 43883, 2022
Mandates: US National Institutes of Health
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine
DV Iosifescu, MH Trivedi, G Sanacora, SJ Mathew, C DeBattista, ...
J Clin Psychiatry 84 (1), 22m14491, 2023
Mandates: US National Institutes of Health
Early Career Psychiatrists Effect of Baseline Anxious Depression on Initial
DF Ionescu, DA Luckenbaugh, MJ Niciu, EM Richards, EE Slonena, ...
J Clin Psychiatry 75 (9), e932-e938, 2014
Mandates: US National Institutes of Health
American Society of Clinical Psychopharmacology Corner
DP Devanand
J Clin Psychiatry 75 (7), 2014
Mandates: US National Institutes of Health
Original Research Clinical Predictors of Ketamine Response
MJ Niciu, DA Luckenbaugh, DF Ionescu, S Guevara, R Machado-Vieira, ...
J Clin Psychiatry 75 (5), e417-e423, 2014
Mandates: US National Institutes of Health
Available somewhere: 45
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
M Fava, MP Freeman, M Flynn, H Judge, BB Hoeppner, C Cusin, ...
Molecular psychiatry 25 (7), 1592-1603, 2020
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research …
Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety
ED Ballard, DF Ionescu, JLV Voort, MJ Niciu, EM Richards, ...
Journal of psychiatric research 58, 161-166, 2014
Mandates: US National Institutes of Health
Do the dissociative side effects of ketamine mediate its antidepressant effects?
DA Luckenbaugh, MJ Niciu, DF Ionescu, NM Nolan, EM Richards, ...
Journal of affective disorders 159, 56-61, 2014
Mandates: US National Institutes of Health
Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
MJ Niciu, DF Ionescu, EM Richards, CA Zarate
Journal of neural transmission 121, 907-924, 2014
Mandates: US National Institutes of Health
Clinical predictors of ketamine response in treatment-resistant major depression
MJ Niciu, DALDF Ionescu, S Guevara, R Machado-Vieira, EM Richards, ...
The Journal of clinical psychiatry 75 (5), 2921, 2014
Mandates: US National Institutes of Health
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial
DF Ionescu, KH Bentley, M Eikermann, N Taylor, O Akeju, MB Swee, ...
Journal of affective disorders 243, 516-524, 2019
Mandates: US National Institutes of Health
Neurobiology of anxious depression: a review
DF Ionescu, MJ Niciu, DC Mathews, EM Richards, CA Zarate Jr
Depression and anxiety 30 (4), 374-385, 2013
Mandates: US National Institutes of Health
Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study
DF Ionescu, MB Swee, KJ Pavone, N Taylor, O Akeju, L Baer, M Nyer, ...
The Journal of clinical psychiatry 77 (6), 10114, 2016
Mandates: US National Institutes of Health
A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
DF Ionescu, DA Luckenbaugh, MJ Niciu, EM Richards, CA Zarate Jr
Bipolar disorders 17 (4), 438-443, 2015
Mandates: US National Institutes of Health
Defining anxious depression: a review of the literature
DF Ionescu, MJ Niciu, ID Henter, CA Zarate
CNS spectrums 18 (5), 252-260, 2013
Mandates: US National Institutes of Health
Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation
C Cusin, DF Ionescu, KJ Pavone, O Akeju, P Cassano, N Taylor, ...
Australian & New Zealand Journal of Psychiatry 51 (1), 55-64, 2017
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program